SERPINA1 and hyperinsulinemic hypoglycemia, familial, 4: To date, alpha-1 antitrypsin augmentation is the only treatment showing the ability of reducing circulating desmosine levels in a randomised trial although the magnitude of treatment effect was small26 and it is currently only relevant to alpha-1 antitrypsin deficiency, a rare genetic condition that is associated with emphysema.